Français
ItalianoBond Amgen 2.3% ( US031162BF68 ) in USD
| Issuer | Amgen | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 US031162BF68 ( in USD )
|
||||||
| Interest rate | 2.3% per year ( payment 2 times a year) | ||||||
| Maturity | 15/06/2016 - Bond has expired | ||||||
|
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 750 000 000 USD | ||||||
| Cusip | 031162BF6 | ||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||
| Detailed description |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. Amgen's USD 750,000,000 2.3% Notes due June 15, 2016 (CUSIP: 031162BF6, ISIN: US031162BF68), rated A by S&P and Baa1 by Moody's, matured and was redeemed at 100% of face value. |
||||||
| |||||||
